Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.90 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.90 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.90 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.90 |
| ▸ | FAAH | O00519 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | CNR1 | P21554 | 1/20 | 0.74 |
| ▸ | CNR2 | P34972 | 1/20 | 0.74 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.73 |
| ▸ | SELP | P16109 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10452609 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL19564925 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL6524506 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL16431079 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL1879786 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL3182554 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL17512151 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL2477265 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL3181278 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL10492136 | 0.99 | PRKCA (0.92) | PRKCAPRKCEPRKCQPRKCDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867771-B2 | Waxes derived from metathesized natural oils and amines and methods of making | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-01-16 | — | — | US | disclosed |
| US-9867771-B2 | Waxes derived from metathesized natural oils and amines and methods of making | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160317428-A1 | Waxes Derived from Metathesized Natural Oils and Amines and Methods of Making | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-11-03 | — | — | US | disclosed |
| US-9315748-B2 | Cold flow additives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-9249360-B2 | Compositions derived from metathesized natural oils and amines and methods of making | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20120255222-A1 | COLD FLOW ADDITIVES | WILMAR TRADING PTE LTD (SG) | 2012-10-11 | — | — | US | disclosed |
| US-20120010303-A1 | WAXES DERIVED FROM METATHESIZED NATURAL OILS AND AMINES AND METHODS OF MAKING | WILMAR TRADING PTE LTD (SG) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317428-A1 | Waxes Derived from Metathesized Natural Oils and Amines and Methods of Making | PNMT, SQLE, SRM | PRKCA 3970/4885PRKCE 3756/4885PRKCQ 3899/4885 |
| US-20120010303-A1 | WAXES DERIVED FROM METATHESIZED NATURAL OILS AND AMINES AND METHODS OF MAKING | PNMT, SQLE, SRM | PRKCA 3970/4885PRKCE 3756/4885PRKCQ 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.